| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.879 | 0.004 | 0.885 | Caspase 9 stimulant | 0.885 0.004 CID_154699518 | CID_154699518 | |
| 0.784 | 0.005 | 0.784 | 12-Lipoxygenase inhibitor | |||
| 0.779 | 0.004 | 0.831 | Free radical scavenger | 0.831 0.004 CID_154699518 | CID_154699518 | |
| 0.772 | 0.002 | 0.772 | Cystathionine beta-synthase inhibitor | 0.715 0.002 CID_154699518 | ||
| 0.764 | 0.007 | 0.764 | Aryl hydrocarbon receptor agonist | 0.246 0.08 CID_154699518 | ||
| 0.763 | 0.008 | 0.763 | 15-Lipoxygenase inhibitor | |||
| 0.768 | 0.02 | 0.785 | Apoptosis agonist | 0.785 0.018 CID_154699518 | CID_154699518 | |
| 0.748 | 0.002 | 0.748 | Peroxidase inhibitor | 0.172 0.068 CID_154699518 | ||
| 0.748 | 0.005 | 0.859 | Antioxidant | 0.859 0.004 CID_154699518 | CID_154699518 | |
| 0.727 | 0.006 | 0.727 | Aldehyde oxidase inhibitor | |||
| 0.694 | 0.004 | 0.694 | Superoxide dismutase inhibitor | 0.188 0.131 CID_154699518 | ||
| 0.69 | 0.035 | 0.901 | Alpha-glucosidase inhibitor | 0.901 0.007 CID_154699518 | CID_154699518 | |
| 0.635 | 0.008 | 0.787 | Histamine release inhibitor | 0.787 0.004 CID_154699518 | CID_154699518 | |
| 0.628 | 0.003 | 0.628 | NADPH oxidase inhibitor | 0.621 0.003 CID_154699518 | ||
| 0.628 | 0.008 | 0.628 | Lipoxygenase inhibitor | |||
| 0.613 | 0.007 | 0.642 | Hypoxia-inducible factor 1 alpha inhibitor | 0.642 0.005 CID_154699518 | CID_154699518 | |
| 0.608 | 0.005 | 0.608 | MAO inhibitor | |||
| 0.61 | 0.006 | 0.61 | GABA C receptor rho-3 antagonist | |||
| 0.607 | 0.01 | 0.711 | 5 Hydroxytryptamine release inhibitor | 0.711 0.004 CID_154699518 | CID_154699518 | |
| 0.592 | 0.008 | 0.592 | Amyloid beta aggregation inhibitor | 0.478 0.016 CID_154699518 | ||
| 0.588 | 0.011 | 0.588 | Caspase 3 stimulant | 0.533 0.016 CID_154699518 | ||
| 0.579 | 0.004 | 0.579 | Breast cancer-resistant protein inhibitor | 0.114 0.044 CID_154699518 | ||
| 0.576 | 0.004 | 0.576 | MAO A inhibitor | |||
| 0.591 | 0.032 | 0.815 | Transcription factor NF kappa B inhibitor | 0.815 0.012 CID_154699518 | CID_154699518 | |
| 0.544 | 0.006 | 0.826 | Monophenol monooxygenase inhibitor | 0.826 0.003 CID_154699518 | CID_154699518 | |
| 0.538 | 0.006 | 0.538 | P-glycoprotein inhibitor | 0.339 0.023 CID_154699518 | ||
| 0.526 | 0.004 | 0.526 | Interleukin 4 antagonist | 0.272 0.011 CID_154699518 | ||
| 0.522 | 0.007 | 0.522 | Pyruvate kinase inhibitor | 0.234 0.066 CID_154699518 | ||
| 0.517 | 0.004 | 0.72 | Xanthine oxidase inhibitor | 0.72 0.002 CID_154699518 | CID_154699518 | |
| 0.502 | 0.003 | 0.502 | Carbonic anhydrase III inhibitor | 0.274 0.007 CID_154699518 | ||
| 0.504 | 0.005 | 0.784 | Amylase inhibitor | 0.784 0.002 CID_154699518 | CID_154699518 | |
| 0.515 | 0.018 | 0.636 | Apoptosis antagonist | 0.636 0.006 CID_154699518 | CID_154699518 | |
| 0.531 | 0.035 | 0.531 | Prostaglandin dehydrogenase inhibitor | |||
| 0.498 | 0.016 | 0.865 | Vasodilator, coronary | 0.865 0.003 CID_154699518 | CID_154699518 | |
| 0.484 | 0.002 | 0.484 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.13 0.025 CID_154699518 | ||
| 0.485 | 0.005 | 0.485 | 5 Hydroxytryptamine uptake stimulant | 0.191 0.17 CID_154699518 | ||
| 0.473 | 0.003 | 0.618 | Carbonic anhydrase XIII inhibitor | 0.618 0.003 CID_154699518 | CID_154699518 | |
| 0.47 | 0.005 | 0.47 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.345 0.013 CID_154699518 | ||
| 0.473 | 0.009 | 0.473 | Dual specificity phosphatase 3 inhibitor | |||
| 0.469 | 0.005 | 0.566 | NOS3 expression enhancer | 0.566 0.004 CID_154699518 | CID_154699518 | |
| 0.534 | 0.074 | 0.813 | Antiinflammatory | 0.813 0.014 CID_154699518 | CID_154699518 | |
| 0.464 | 0.008 | 0.464 | Dual specificity phosphatase inhibitor | |||
| 0.453 | 0.004 | 0.453 | Carbonic anhydrase VI inhibitor | 0.226 0.01 CID_154699518 | ||
| 0.443 | 0.003 | 0.443 | Creatine kinase inhibitor | 0.122 0.039 CID_154699518 | ||
| 0.449 | 0.014 | 0.449 | RNA-directed DNA polymerase inhibitor | 0.347 0.024 CID_154699518 | ||
| 0.44 | 0.009 | 0.647 | Melanin inhibitor | 0.647 0.004 CID_154699518 | CID_154699518 | |
| 0.441 | 0.013 | 0.441 | Transcription factor STAT inhibitor | |||
| 0.452 | 0.027 | 0.452 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.443 | 0.021 | 0.628 | Nitric oxide antagonist | 0.628 0.008 CID_154699518 | CID_154699518 | |
| 0.429 | 0.006 | 0.52 | Protein kinase stimulant | 0.52 0.004 CID_154699518 | CID_154699518 | |
| 0.428 | 0.005 | 0.428 | Acetylcholinesterase inhibitor | 0.202 0.033 CID_154699518 | ||
| 0.423 | 0.007 | 0.423 | MAO B inhibitor | |||
| 0.431 | 0.018 | 0.515 | Vasodilator | 0.515 0.011 CID_154699518 | CID_154699518 | |
| 0.421 | 0.009 | 0.489 | Lipid peroxidase inhibitor | 0.489 0.005 CID_154699518 | CID_154699518 | |
| 0.421 | 0.009 | 0.447 | Topoisomerase II inhibitor | 0.447 0.008 CID_154699518 | CID_154699518 | |
| 0.435 | 0.024 | 0.618 | Antiamyloidogenic | 0.618 0.007 CID_154699518 | CID_154699518 | |
| 0.415 | 0.004 | 0.415 | Topoisomerase II alpha inhibitor | 0.382 0.005 CID_154699518 | ||
| 0.421 | 0.011 | 0.654 | Non-steroidal antiinflammatory agent | 0.654 0.004 CID_154699518 | CID_154699518 | |
| 0.429 | 0.023 | 0.737 | Hypoglycemic | 0.737 0.005 CID_154699518 | CID_154699518 | |
| 0.442 | 0.038 | 0.442 | 5 Hydroxytryptamine release stimulant | 0.344 0.058 CID_154699518 | ||
| 0.426 | 0.023 | 0.614 | Tumour necrosis factor alpha release inhibitor | 0.614 0.007 CID_154699518 | CID_154699518 | |
| 0.403 | 0.004 | 0.403 | Macrophage migration inhibitory factor inhibitor | |||
| 0.398 | 0.009 | 0.481 | DNA methyltransferase I inhibitor | 0.481 0.005 CID_154699518 | CID_154699518 | |
| 0.392 | 0.012 | 0.392 | Tubulin antagonist | 0.101 0.1 CID_154699518 | ||
| 0.415 | 0.037 | 0.646 | Spasmolytic | 0.646 0.009 CID_154699518 | CID_154699518 | |
| 0.393 | 0.03 | 0.545 | DNA damaging | 0.545 0.011 CID_154699518 | CID_154699518 | |
| 0.364 | 0.004 | 0.43 | Nitric-oxide synthase stimulant | 0.43 0.003 CID_154699518 | CID_154699518 | |
| 0.357 | 0.004 | 0.357 | Electron transport complex I inhibitor | 0.126 0.039 CID_154699518 | ||
| 0.36 | 0.007 | 0.543 | Alkaline phosphatase inhibitor | 0.543 0.004 CID_154699518 | CID_154699518 | |
| 0.356 | 0.005 | 0.356 | Telomerase inhibitor | 0.068 0.055 CID_154699518 | ||
| 0.365 | 0.014 | 0.471 | DNA methylase inhibitor | 0.471 0.007 CID_154699518 | CID_154699518 | |
| 0.354 | 0.007 | 0.354 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.355 | 0.01 | 0.355 | Tumour necrosis factor antagonist | |||
| 0.447 | 0.102 | 0.447 | DNA polymerase beta inhibitor | |||
| 0.355 | 0.012 | 0.355 | Protein-tyrosine phosphatase inhibitor | 0.265 0.027 CID_154699518 | ||
| 0.337 | 0.003 | 0.337 | Multidrug resistance-associated protein 1 inhibitor | 0.257 0.005 CID_154699518 | ||
| 0.335 | 0.006 | 0.335 | Carbonic anhydrase XV inhibitor | |||
| 0.349 | 0.019 | 0.609 | Hepatoprotectant | 0.609 0.004 CID_154699518 | CID_154699518 | |
| 0.339 | 0.014 | 0.339 | Cholinergic | 0.136 0.089 CID_154699518 | ||
| 0.328 | 0.007 | 0.328 | Succinate dehydrogenase inhibitor | 0.16 0.095 CID_154699518 | ||
| 0.397 | 0.078 | 0.698 | Antibacterial | 0.698 0.009 CID_154699518 | CID_154699518 | |
| 0.373 | 0.055 | 0.373 | Streptokinase A inhibitor | |||
| 0.326 | 0.012 | 0.326 | Amyloid beta precursor protein antagonist | |||
| 0.419 | 0.108 | 0.419 | DNA directed DNA polymerase inhibitor | |||
| 0.319 | 0.014 | 0.319 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.309 | 0.005 | 0.309 | GABA C receptor rho-2 antagonist | |||
| 0.297 | 0.003 | 0.297 | Xanthine dehydrogenase inhibitor | 0.126 0.01 CID_154699518 | ||
| 0.296 | 0.011 | 0.296 | 5-Lipoxygenase inhibitor | |||
| 0.322 | 0.041 | 0.761 | Angiogenesis stimulant | 0.761 0.004 CID_154699518 | CID_154699518 | |
| 0.291 | 0.011 | 0.291 | Butyrylcholinesterase inhibitor | |||
| 0.293 | 0.012 | 0.301 | Aldehyde dehydrogenase inhibitor | 0.301 0.012 CID_154699518 | CID_154699518 | |
| 0.29 | 0.012 | 0.29 | Chelator | 0.121 0.052 CID_154699518 | ||
| 0.32 | 0.044 | 0.32 | Transcription factor STAT3 inhibitor | |||
| 0.305 | 0.032 | 0.461 | Platelet adhesion inhibitor | 0.461 0.007 CID_154699518 | CID_154699518 | |
| 0.273 | 0.004 | 0.273 | Histone deacetylase stimulant | 0.193 0.005 CID_154699518 | ||
| 0.273 | 0.004 | 0.273 | Histone deacetylase SIRT1 stimulant | 0.193 0.005 CID_154699518 | ||
| 0.28 | 0.013 | 0.28 | Protein kinase (CK2) alpha inhibitor | |||
| 0.299 | 0.034 | 0.299 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.267 | 0.006 | 0.267 | HIV-1 integrase (3'-Processing) inhibitor | 0.109 0.023 CID_154699518 | ||
| 0.264 | 0.005 | 0.264 | Aldose reductase inhibitor | 0.263 0.005 CID_154699518 | ||
| 0.277 | 0.018 | 0.277 | Cytokine production inhibitor | |||
| 0.261 | 0.005 | 0.389 | Photosensitizer | 0.389 0.003 CID_154699518 | CID_154699518 | |
| 0.297 | 0.044 | 0.297 | Antimitotic | |||
| 0.256 | 0.006 | 0.256 | HIV-1 integrase (Strand Transfer) inhibitor | 0.099 0.023 CID_154699518 | ||
| 0.249 | 0.003 | 0.249 | D-Ala-D-Ala ligase inhibitor | |||
| 0.252 | 0.007 | 0.252 | Estrogen receptor beta antagonist | |||
| 0.326 | 0.082 | 0.326 | Thyroid hormone antagonist | |||
| 0.318 | 0.078 | 0.751 | Antithrombotic | 0.751 0.005 CID_154699518 | CID_154699518 | |
| 0.24 | 0.003 | 0.24 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.178 0.005 CID_154699518 | ||
| 0.251 | 0.016 | 0.251 | Protein-tyrosine phosphatase 1B inhibitor | 0.221 0.023 CID_154699518 | ||
| 0.243 | 0.009 | 0.243 | Estrogen antagonist | 0.117 0.061 CID_154699518 | ||
| 0.287 | 0.054 | 0.287 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.236 | 0.004 | 0.236 | Heat shock protein 70 antagonist | 0.222 0.005 CID_154699518 | ||
| 0.242 | 0.014 | 0.254 | Mannose-6-phosphate isomerase inhibitor | 0.254 0.011 CID_154699518 | CID_154699518 | |
| 0.327 | 0.099 | 0.526 | Immunosuppressant | 0.526 0.026 CID_154699518 | CID_154699518 | |
| 0.316 | 0.089 | 0.316 | Vasodilator, peripheral | 0.244 0.132 CID_154699518 | ||
| 0.235 | 0.009 | 0.235 | Uric acid excretion stimulant | 0.22 0.01 CID_154699518 | ||
| 0.25 | 0.026 | 0.25 | Heat shock protein 90 alpha antagonist | |||
| 0.307 | 0.084 | 0.307 | Thyroid hormone beta antagonist | |||
| 0.243 | 0.023 | 0.243 | Heat shock protein 90 antagonist | |||
| 0.221 | 0.005 | 0.221 | Myeloperoxidase inhibitor | |||
| 0.222 | 0.008 | 0.222 | Aromatase inhibitor | |||
| 0.215 | 0.005 | 0.215 | CDC25A inhibitor | 0.087 0.037 CID_154699518 | ||
| 0.213 | 0.004 | 0.213 | Carbonic anhydrase VII inhibitor | 0.14 0.007 CID_154699518 | ||
| 0.233 | 0.028 | 0.233 | Bone formation stimulant | 0.157 0.053 CID_154699518 | ||
| 0.277 | 0.074 | 0.277 | Insulysin inhibitor | |||
| 0.227 | 0.025 | 0.317 | Insulin secretagoues | 0.317 0.011 CID_154699518 | CID_154699518 | |
| 0.238 | 0.04 | 0.238 | Mcl-1 antagonist | |||
| 0.209 | 0.011 | 0.215 | Alcohol dehydrogenase inhibitor | 0.215 0.011 CID_154699518 | CID_154699518 | |
| 0.231 | 0.036 | 0.231 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.202 | 0.007 | 0.202 | Carbonic anhydrase V inhibitor | |||
| 0.237 | 0.043 | 0.237 | Insulin sensitizer | 0.223 0.052 CID_154699518 | ||
| 0.209 | 0.017 | 0.209 | Protein kinase (CK2) inhibitor | |||
| 0.195 | 0.005 | 0.195 | CD45 antagonist | |||
| 0.203 | 0.012 | 0.625 | Beta glucuronidase inhibitor | 0.625 0.003 CID_154699518 | CID_154699518 | |
| 0.258 | 0.069 | 0.258 | Dyrk kinase inhibitor | |||
| 0.222 | 0.033 | 0.222 | Cyclooxygenase inhibitor | 0.219 0.034 CID_154699518 | ||
| 0.204 | 0.017 | 0.549 | Cyclooxygenase 3 inhibitor | 0.549 0.003 CID_154699518 | CID_154699518 | |
| 0.324 | 0.137 | 0.324 | Calcium channel L-type activator | |||
| 0.214 | 0.029 | 0.214 | Cyclooxygenase 1 inhibitor | 0.155 0.054 CID_154699518 | ||
| 0.19 | 0.012 | 0.19 | Protein kinase C zeta inhibitor | |||
| 0.229 | 0.052 | 0.241 | Neurotrophic factor enhancer | 0.241 0.044 CID_154699518 | CID_154699518 | |
| 0.2 | 0.024 | 0.2 | Toll-Like receptor 2 antagonist | |||
| 0.179 | 0.006 | 0.179 | Carbonic anhydrase VA inhibitor | |||
| 0.185 | 0.012 | 0.185 | Urease inhibitor | |||
| 0.177 | 0.005 | 0.177 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.185 | 0.014 | 0.42 | AMP-activated protein kinase stimulant | 0.42 0.004 CID_154699518 | CID_154699518 | |
| 0.28 | 0.113 | 0.28 | Calcium channel activator | |||
| 0.18 | 0.013 | 0.393 | DNA repair enzyme inhibitor | 0.393 0.003 CID_154699518 | CID_154699518 | |
| 0.17 | 0.005 | 0.17 | Protease activated receptor antagonist | 0.068 0.037 CID_154699518 | ||
| 0.19 | 0.029 | 0.311 | Topoisomerase I inhibitor | 0.311 0.01 CID_154699518 | CID_154699518 | |
| 0.178 | 0.017 | 0.178 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.173 | 0.012 | 0.173 | Transcription factor STAT6 inhibitor | |||
| 0.203 | 0.042 | 0.203 | Phospholipase C inhibitor | 0.171 0.072 CID_154699518 | ||
| 0.171 | 0.014 | 0.171 | GABA C receptor rho-1 antagonist | |||
| 0.166 | 0.01 | 0.166 | Cyclin B3 inhibitor | |||
| 0.186 | 0.031 | 0.186 | CF transmembrane conductance regulator agonist | 0.134 0.108 CID_154699518 | ||
| 0.187 | 0.035 | 0.192 | Cyclooxygenase 2 inhibitor | 0.192 0.033 CID_154699518 | CID_154699518 | |
| 0.156 | 0.005 | 0.156 | Aryl hydrocarbon receptor antagonist | |||
| 0.227 | 0.076 | 0.227 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.169 | 0.019 | 0.169 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.157 | 0.009 | 0.172 | T cell inhibitor | 0.172 0.009 CID_154699518 | CID_154699518 | |
| 0.19 | 0.043 | 0.19 | Arachidonic acid antagonist | |||
| 0.155 | 0.009 | 0.155 | Thioredoxin reductase inhibitor | 0.085 0.05 CID_154699518 | ||
| 0.157 | 0.011 | 0.157 | Estrogen receptor alpha antagonist | |||
| 0.147 | 0.003 | 0.147 | Glutamate (mGluR7) antagonist | 0.062 0.058 CID_154699518 | ||
| 0.181 | 0.042 | 0.522 | Hemostatic | 0.522 0.004 CID_154699518 | CID_154699518 | |
| 0.158 | 0.021 | 0.158 | Sphingomyelinase inhibitor | 0.133 0.033 CID_154699518 | ||
| 0.156 | 0.019 | 0.156 | DOPA decarboxylase inhibitor | |||
| 0.142 | 0.005 | 0.142 | Fatty acid synthase inhibitor | 0.075 0.021 CID_154699518 | ||
| 0.202 | 0.066 | 0.202 | Histone acetyltransferase inhibitor | |||
| 0.14 | 0.008 | 0.14 | CDC25B inhibitor | |||
| 0.137 | 0.005 | 0.137 | Potassium channel Kv1.3 blocker | |||
| 0.141 | 0.01 | 0.141 | Alpha tubulin antagonist | |||
| 0.29 | 0.16 | 0.29 | Transcription factor inhibitor | |||
| 0.145 | 0.018 | 0.145 | CYP2A6 inhibitor | |||
| 0.137 | 0.011 | 0.137 | HIV-1 integrase inhibitor | 0.066 0.054 CID_154699518 | ||
| 0.137 | 0.014 | 0.137 | Beta tubulin antagonist | |||
| 0.129 | 0.006 | 0.205 | Carbonic anhydrase XIV inhibitor | 0.205 0.004 CID_154699518 | CID_154699518 | |
| 0.15 | 0.028 | 0.15 | Potassium channel (Ca-activated) activator | |||
| 0.197 | 0.076 | 0.197 | Anesthetic general | 0.192 0.079 CID_154699518 | ||
| 0.144 | 0.024 | 0.144 | Calcium antagonist | |||
| 0.132 | 0.013 | 0.132 | Estrogen agonist | 0.098 0.018 CID_154699518 | ||
| 0.139 | 0.02 | 0.165 | Thioredoxin inhibitor | 0.165 0.013 CID_154699518 | CID_154699518 | |
| 0.173 | 0.055 | 0.331 | Interferon gamma antagonist | 0.331 0.016 CID_154699518 | CID_154699518 | |
| 0.149 | 0.031 | 0.149 | GABA C receptor antagonist | |||
| 0.2 | 0.084 | 0.2 | Interleukin antagonist | 0.136 0.129 CID_154699518 | ||
| 0.247 | 0.131 | 0.247 | Sodium/bile acid cotransporter inhibitor | |||
| 0.243 | 0.13 | 0.488 | Cholesterol antagonist | 0.488 0.035 CID_154699518 | CID_154699518 | |
| 0.154 | 0.044 | 0.316 | Alkylator | 0.316 0.012 CID_154699518 | CID_154699518 | |
| 0.141 | 0.033 | 0.397 | Mediator release inhibitor | 0.397 0.005 CID_154699518 | CID_154699518 | |
| 0.137 | 0.029 | 0.185 | Toll-Like receptor 4 antagonist | 0.185 0.009 CID_154699518 | CID_154699518 | |
| 0.13 | 0.023 | 0.13 | Histidine decarboxylase inhibitor | |||
| 0.121 | 0.015 | 0.121 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.171 | 0.067 | 0.171 | Death-associated protein kinase 2 inhibitor | |||
| 0.149 | 0.045 | 0.149 | Ca2+-transporting ATPase inhibitor | 0.144 0.06 CID_154699518 | ||
| 0.186 | 0.084 | 0.186 | I kappa B kinase epsilon inhibitor | |||
| 0.125 | 0.026 | 0.125 | Phosphodiesterase 4D inhibitor | |||
| 0.102 | 0.006 | 0.102 | Transcription factor RelA inhibitor | |||
| 0.1 | 0.004 | 0.1 | Ryanodine receptor antagonist | |||
| 0.113 | 0.018 | 0.234 | Carbonic anhydrase XII inhibitor | 0.234 0.007 CID_154699518 | CID_154699518 | |
| 0.124 | 0.031 | 0.124 | Androgen antagonist | |||
| 0.276 | 0.184 | 0.789 | Cyclophilin D inhibitor | 0.789 0.007 CID_154699518 | CID_154699518 | |
| 0.151 | 0.061 | 0.151 | Adenylate cyclase stimulant | |||
| 0.14 | 0.05 | 0.14 | Cholesterol synthesis inhibitor | 0.106 0.08 CID_154699518 | ||
| 0.133 | 0.043 | 0.43 | Expectorant | 0.43 0.004 CID_154699518 | CID_154699518 | |
| 0.108 | 0.019 | 0.108 | Leukotriene antagonist | 0.084 0.029 CID_154699518 | ||
| 0.113 | 0.024 | 0.113 | Keratolytic | |||
| 0.126 | 0.037 | 0.272 | Antineoplastic antibiotic | 0.272 0.012 CID_154699518 | CID_154699518 | |
| 0.11 | 0.022 | 0.11 | Lipase inhibitor | 0.066 0.058 CID_154699518 | ||
| 0.093 | 0.005 | 0.093 | Dopamine D5 agonist | |||
| 0.099 | 0.012 | 0.099 | Estrogen receptor beta agonist | 0.038 0.022 CID_154699518 | ||
| 0.117 | 0.032 | 0.218 | Interleukin 12 antagonist | 0.218 0.005 CID_154699518 | CID_154699518 | |
| 0.129 | 0.046 | 0.147 | Mucolytic | 0.147 0.034 CID_154699518 | CID_154699518 | |
| 0.111 | 0.03 | 0.111 | Interleukin 5 antagonist | 0.11 0.032 CID_154699518 | ||
| 0.105 | 0.024 | 0.105 | Caspase 7 inhibitor | |||
| 0.132 | 0.053 | 0.132 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.105 | 0.028 | 0.105 | mTOR complex 2 inhibitor | |||
| 0.115 | 0.04 | 0.115 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.09 | 0.015 | 0.09 | Heat shock protein 90 beta antagonist | |||
| 0.099 | 0.024 | 0.099 | Potassium channel large-conductance Ca-activated activator | |||
| 0.124 | 0.05 | 0.124 | Nav1.5 sodium channel blocker | |||
| 0.099 | 0.026 | 0.099 | Estrogen-related receptor beta agonist | |||
| 0.125 | 0.053 | 0.125 | TRPA1 agonist | |||
| 0.156 | 0.091 | 0.295 | ATPase inhibitor | 0.295 0.006 CID_154699518 | CID_154699518 | |
| 0.07 | 0.005 | 0.07 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.144 | 0.08 | 0.144 | Phospholipase A2 inhibitor | |||
| 0.084 | 0.021 | 0.084 | Beta 3 adrenoreceptor antagonist | |||
| 0.135 | 0.073 | 0.135 | Toll-Like receptor 9 antagonist | |||
| 0.092 | 0.031 | 0.092 | Adenosine A3 receptor antagonist | |||
| 0.082 | 0.021 | 0.082 | Carbonic anhydrase VB inhibitor | |||
| 0.069 | 0.009 | 0.069 | GABA B receptor antagonist | |||
| 0.102 | 0.042 | 0.179 | NADH dehydrogenase inhibitor | 0.179 0.013 CID_154699518 | CID_154699518 | |
| 0.082 | 0.023 | 0.082 | Alcohol oxidase inhibitor | |||
| 0.072 | 0.013 | 0.072 | Estrogen receptor alpha agonist | |||
| 0.101 | 0.043 | 0.101 | Ornithine decarboxylase inhibitor | |||
| 0.104 | 0.045 | 0.104 | ABCA1 expression enhancer | |||
| 0.153 | 0.095 | 0.153 | Neurotensin receptor agonist | |||
| 0.117 | 0.06 | 0.176 | DNA intercalator | 0.176 0.033 CID_154699518 | CID_154699518 | |
| 0.068 | 0.012 | 0.068 | DNA-dependent protein kinase inhibitor | |||
| 0.097 | 0.041 | 0.097 | Glutathione S-transferase inhibitor | |||
| 0.081 | 0.025 | 0.105 | Neuraminidase inhibitor | 0.105 0.014 CID_154699518 | CID_154699518 | |
| 0.069 | 0.016 | 0.117 | Glucose-6-phosphate translocase inhibitor | 0.117 0.004 CID_154699518 | CID_154699518 | |
| 0.125 | 0.073 | 0.125 | Antibacterial (Helicobacter pylori) | |||
| 0.066 | 0.015 | 0.066 | CXC chemokine 1 receptor antagonist | |||
| 0.068 | 0.017 | 0.068 | Leukotriene C antagonist | |||
| 0.105 | 0.055 | 0.227 | UDP-glucose 4-epimerase inhibitor | 0.227 0.015 CID_154699518 | CID_154699518 | |
| 0.075 | 0.026 | 0.075 | Protein kinase C eta inhibitor | |||
| 0.084 | 0.035 | 0.084 | Leukotriene synthesis inhibitor | |||
| 0.096 | 0.048 | 0.096 | Phosphodiesterase IV inhibitor | |||
| 0.116 | 0.069 | 0.116 | Proteasome inhibitor | |||
| 0.089 | 0.042 | 0.127 | Na+ K+ transporting ATPase inhibitor | 0.127 0.013 CID_154699518 | CID_154699518 | |
| 0.053 | 0.008 | 0.053 | Catechol O-methyltransferase inhibitor | |||
| 0.052 | 0.007 | 0.052 | Vanilloid 3 antagonist | |||
| 0.056 | 0.013 | 0.056 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.069 | 0.026 | 0.069 | Sphingosine kinase inhibitor | |||
| 0.065 | 0.023 | 0.095 | Leukotriene B4 antagonist | 0.095 0.011 CID_154699518 | CID_154699518 | |
| 0.07 | 0.029 | 0.085 | Maillard reaction inhibitor | 0.085 0.022 CID_154699518 | CID_154699518 | |
| 0.094 | 0.053 | 0.105 | Glutamate release inhibitor | 0.105 0.036 CID_154699518 | CID_154699518 | |
| 0.089 | 0.048 | 0.089 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.109 | 0.068 | 0.11 | Acetylcholine release stimulant | 0.11 0.065 CID_154699518 | CID_154699518 | |
| 0.072 | 0.033 | 0.115 | Neuraminidase (influenza) inhibitor | 0.115 0.013 CID_154699518 | CID_154699518 | |
| 0.118 | 0.079 | 0.219 | Alpha-N-acetylglucosaminidase inhibitor | 0.219 0.029 CID_154699518 | CID_154699518 | |
| 0.07 | 0.031 | 0.07 | CDK4/cyclin D1 inhibitor | |||
| 0.096 | 0.058 | 0.096 | Bile acid receptor antagonist | |||
| 0.059 | 0.021 | 0.059 | Squalene epoxidase inhibitor | |||
| 0.113 | 0.075 | 0.149 | Beta amyloid protein antagonist | 0.149 0.042 CID_154699518 | CID_154699518 | |
| 0.045 | 0.007 | 0.045 | Estrogen-related receptor beta antagonist | |||
| 0.069 | 0.033 | 0.069 | Purinergic P2X1 antagonist | |||
| 0.134 | 0.099 | 0.251 | Hexokinase inhibitor | 0.251 0.017 CID_154699518 | CID_154699518 | |
| 0.095 | 0.061 | 0.095 | Prolactin inhibitor | |||
| 0.183 | 0.15 | 0.345 | DNA synthesis inhibitor | 0.345 0.031 CID_154699518 | CID_154699518 | |
| 0.049 | 0.016 | 0.097 | Arginase inhibitor | 0.097 0.004 CID_154699518 | CID_154699518 | |
| 0.043 | 0.01 | 0.043 | Protein kinase (CK2) beta inhibitor | |||
| 0.256 | 0.226 | 0.256 | MAP kinase 1 inhibitor | |||
| 0.055 | 0.026 | 0.055 | Topoisomerase II beta inhibitor | 0.049 0.034 CID_154699518 | ||
| 0.147 | 0.119 | 0.183 | Psychostimulant | 0.183 0.091 CID_154699518 | CID_154699518 | |
| 0.044 | 0.015 | 0.044 | Sirtuin 2 inhibitor | |||
| 0.069 | 0.04 | 0.09 | Carbonic anhydrase inhibitor | 0.09 0.031 CID_154699518 | CID_154699518 | |
| 0.043 | 0.014 | 0.043 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.096 | 0.069 | 0.096 | Anabolic | |||
| 0.106 | 0.08 | 0.147 | Microtubule formation inhibitor | 0.147 0.039 CID_154699518 | CID_154699518 | |
| 0.044 | 0.018 | 0.044 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.061 | 0.037 | 0.087 | Carbonic anhydrase IX inhibitor | 0.087 0.024 CID_154699518 | CID_154699518 | |
| 0.058 | 0.035 | 0.058 | Cyclin B2 inhibitor | |||
| 0.068 | 0.045 | 0.068 | Glutamate (mGluR6) antagonist | |||
| 0.064 | 0.045 | 0.064 | Dopamine D1 antagonist | |||
| 0.116 | 0.098 | 0.116 | Vanilloid 1 agonist | |||
| 0.04 | 0.023 | 0.04 | Leukotriene C4 antagonist | |||
| 0.064 | 0.048 | 0.064 | Beta adrenoreceptor antagonist | |||
| 0.056 | 0.04 | 0.056 | Pregnane X receptor antagonist | |||
| 0.027 | 0.012 | 0.027 | Estrone sulfatase inhibitor | |||
| 0.073 | 0.057 | 0.073 | GABA aminotransferase inhibitor | 0.068 0.066 CID_154699518 | ||
| 0.072 | 0.057 | 0.102 | Phosphodiesterase VI inhibitor | 0.102 0.019 CID_154699518 | CID_154699518 | |
| 0.119 | 0.106 | 0.119 | Farnesoid X receptor antagonist | |||
| 0.117 | 0.104 | 0.117 | Cytidine deaminase inhibitor | |||
| 0.058 | 0.046 | 0.058 | Cyclin B1 inhibitor | |||
| 0.052 | 0.04 | 0.052 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.046 | 0.034 | 0.046 | Adenosine deaminase inhibitor | |||
| 0.026 | 0.015 | 0.026 | Dopamine autoreceptor agonist | |||
| 0.021 | 0.01 | 0.035 | Antibiotic Anthracycline-like | 0.035 0.003 CID_154699518 | CID_154699518 | |
| 0.045 | 0.034 | 0.045 | Adenylate cyclase 1 inhibitor | |||
| 0.052 | 0.041 | 0.052 | GABA receptor antagonist | |||
| 0.068 | 0.058 | 0.068 | Glutamate decarboxylase inhibitor | |||
| 0.155 | 0.144 | 0.324 | Cyclic AMP phosphodiesterase inhibitor | 0.324 0.033 CID_154699518 | CID_154699518 | |
| 0.082 | 0.072 | 0.159 | Triose-phosphate isomerase inhibitor | 0.159 0.018 CID_154699518 | CID_154699518 | |
| 0.04 | 0.033 | 0.04 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.105 | 0.098 | 0.105 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.023 | 0.016 | 0.023 | Dopamine D1 agonist | |||
| 0.071 | 0.064 | 0.071 | GABA B receptor agonist | |||
| 0.045 | 0.038 | 0.045 | Cholesterol esterase inhibitor | |||
| 0.039 | 0.033 | 0.039 | Dopamine D5 antagonist | |||
| 0.051 | 0.046 | 0.051 | DNA helicase inhibitor | |||
| 0.041 | 0.037 | 0.041 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.155 | 0.151 | 0.523 | Immunostimulant | 0.523 0.026 CID_154699518 | CID_154699518 | |
| 0.03 | 0.026 | 0.03 | ATP citrate lysase inhibitor | |||
| 0.017 | 0.016 | 0.017 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.087 | 0.085 | 0.126 | Phosphodiesterase 6D inhibitor | 0.126 0.02 CID_154699518 | CID_154699518 | |
| 0.086 | 0.085 | 0.086 | GABA C receptor agonist | |||
| 0.056 | 0.055 | 0.056 | Dopamine agonist | |||
| 0.055 | 0.055 | 0.058 | Transcription factor AP-1 inhibitor | 0.058 0.049 CID_154699518 | CID_154699518 | |
| 0.048 | 0.05 | 0.152 | Heparanase inhibitor | 0.152 0.003 CID_154699518 | CID_154699518 | |
| 0.04 | 0.051 | 0.059 | Glucose-6-phosphate isomerase inhibitor | 0.059 0.02 CID_154699518 | CID_154699518 | |
| 0.142 | 0.154 | 0.361 | Platelet antagonist | 0.361 0.036 CID_154699518 | CID_154699518 | |
| 0.076 | 0.088 | 0.108 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.108 0.047 CID_154699518 | CID_154699518 | |
| 0.021 | 0.033 | 0.093 | Sodium/glucose cotransporter 2 inhibitor | 0.093 0.003 CID_154699518 | CID_154699518 | |
| 0.042 | 0.057 | 0.056 | Cytokine production stimulant | 0.056 0.017 CID_154699518 | CID_154699518 | |
| 0.036 | 0.053 | 0.062 | Neuraminidase (Influenza A) inhibitor | 0.062 0.011 CID_154699518 | CID_154699518 | |
| 0.048 | 0.072 | 0.114 | Phosphofructokinase-1 inhibitor | 0.114 0.027 CID_154699518 | CID_154699518 | |
| 0.063 | 0.087 | 0.089 | Interferon agonist | 0.089 0.039 CID_154699518 | CID_154699518 | |
| 0.019 | 0.046 | 0.074 | Sodium/glucose cotransporter inhibitor | 0.074 0.004 CID_154699518 | CID_154699518 | |
| 0.102 | 0.132 | 0.296 | Diuretic | 0.296 0.023 CID_154699518 | CID_154699518 | |
| 0.015 | 0.046 | 0.058 | Protein 30S ribosomal subunit inhibitor | 0.058 0.006 CID_154699518 | CID_154699518 | |
| 0.047 | 0.101 | 0.063 | Interferon inducer | 0.063 0.046 CID_154699518 | CID_154699518 | |
| 0.038 | 0.097 | 0.054 | Factor III inhibitor | 0.054 0.025 CID_154699518 | CID_154699518 | |
| 0.015 | 0.079 | 0.024 | Vanilloid 2 agonist | 0.024 0.02 CID_154699518 | CID_154699518 | |
| 0.005 | 0.072 | 0.017 | Ileal bile acid transport inhibitor | 0.017 0.012 CID_154699518 | CID_154699518 | |
| 0.055 | 0.128 | 0.155 | Falcipain 2 inhibitor | 0.155 0.027 CID_154699518 | CID_154699518 | |
| 0.035 | 0.108 | 0.074 | Nitric oxide donor | 0.074 0.028 CID_154699518 | CID_154699518 | |
| 0.031 | 0.106 | 0.073 | Alpha-mannosidase inhibitor | 0.073 0.015 CID_154699518 | CID_154699518 | |
| 0.022 | 0.098 | 0.076 | Antibiotic Aminoglycoside-like | 0.076 0.005 CID_154699518 | CID_154699518 | |
| 0.056 | 0.133 | 0.157 | Falcipain inhibitor | 0.157 0.028 CID_154699518 | CID_154699518 | |
| 0.106 | 0.184 | 0.193 | Interleukin 6 antagonist | 0.193 0.045 CID_154699518 | CID_154699518 | |
| 0.04 | 0.124 | 0.061 | Adenine nucleotide translocase inhibitor | 0.061 0.026 CID_154699518 | CID_154699518 | |
| 0.043 | 0.127 | 0.065 | Lipocortins synthesis agonist | 0.065 0.027 CID_154699518 | CID_154699518 | |
| 0.064 | 0.149 | 0.13 | DNA polymerase I inhibitor | 0.13 0.061 CID_154699518 | CID_154699518 | |
| 0.02 | 0.113 | 0.066 | Mannosidase inhibitor | 0.066 0.014 CID_154699518 | CID_154699518 | |
| 0.059 | 0.155 | 0.139 | Transcription factor NF kappa B stimulant | 0.139 0.019 CID_154699518 | CID_154699518 | |
| 0.056 | 0.153 | 0.121 | ATPase (Vacuolar H+) inhibitor | 0.121 0.019 CID_154699518 | CID_154699518 | |
| 0.107 | 0.209 | 0.144 | CC chemokine 6 receptor antagonist | 0.144 0.032 CID_154699518 | CID_154699518 | |
| 0.021 | 0.141 | 0.104 | Protein 50S ribosomal subunit inhibitor | 0.104 0.012 CID_154699518 | CID_154699518 | |
| 0.022 | 0.145 | 0.046 | Microtubule stabilization | 0.046 0.033 CID_154699518 | CID_154699518 | |
| 0.042 | 0.167 | 0.074 | Glycine receptor antagonist | 0.074 0.067 CID_154699518 | CID_154699518 | |
| 0.13 | 0.27 | 0.19 | Angiogenesis inhibitor | 0.19 0.182 CID_154699518 | CID_154699518 | |
| 0.082 | 0.244 | 0.246 | Interleukin agonist | 0.246 0.082 CID_154699518 | CID_154699518 | |
| 0.069 | 0.239 | 0.219 | Cell wall synthesis inhibitor | 0.219 0.023 CID_154699518 | CID_154699518 | |
| 0.074 | 0.272 | 0.292 | Hypolipemic | 0.292 0.051 CID_154699518 | CID_154699518 | |
| 0.042 | 0.27 | 0.32 | Thrombolytic | 0.32 0.021 CID_154699518 | CID_154699518 | |
| 0.013 | 0.283 | 0.031 | Toll-Like receptor 4 agonist | 0.031 0.01 CID_154699518 | CID_154699518 | |
| 0.013 | 0.287 | 0.337 | Selectin antagonist | 0.337 0.004 CID_154699518 | CID_154699518 | |
| 0.016 | 0.305 | 0.077 | DNA gyrase inhibitor | 0.077 0.029 CID_154699518 | CID_154699518 | |
| 0.097 | 0.448 | 0.368 | Peptidyltransferase inhibitor | 0.368 0.01 CID_154699518 | CID_154699518 | |
| 0.092 | 0.518 | 0.376 | Interleukin 2 agonist | 0.376 0.035 CID_154699518 | CID_154699518 | |
| 0.041 | 0.641 | 0.398 | Immunomodulator | 0.398 0.044 CID_154699518 | CID_154699518 | |
| 0.013 | 0.627 | 0.188 | Anticoagulant | 0.188 0.058 CID_154699518 | CID_154699518 | |
| 0.014 | 0.628 | 0.056 | Factor IXa inhibitor | 0.056 0.03 CID_154699518 | CID_154699518 | |
| 0.018 | 0.633 | 0.219 | Cell adhesion inhibitor | 0.219 0.02 CID_154699518 | CID_154699518 | |
| 0.008 | 0.692 | 0.08 | Cell adhesion molecule inhibitor | 0.08 0.053 CID_154699518 | CID_154699518 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |